Is NIKLF or MRK a better dividend investment in 2026?

NIKLF currently yields 5882.35% with a 5% 5-year dividend growth rate. MRK yields 3.25% with 8.2% growth. The better choice depends on your goal: NIKLF offers higher current income.

What is the dividend yield difference between NIKLF and MRK?

NIKLF has a forward dividend yield of 5882.35% ($2.00/share annually). MRK yields 3.25% ($3.08/share annually). The yield gap is 5879.10 percentage points.

Home › Compare › NIKLF vs MRK

NIKLF vs MRK: Dividend Comparison 2026

NIKLF yields 5882.35% · MRK yields 3.25%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 NIKLF wins by $302684608132120.06M in total portfolio value

INVESTMENT

TIME HORIZON10 years

NIKLF

● Live price

5882.35%

Share price

$0.03

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$302684608132120.06M

Annual income

$292,889,908,842,934,530,000.00

Full NIKLF calculator →

MRK

Merck & Co. Inc.

● Live price

3.25%

Share price

$94.80

Annual div

$3.08

5Y div CAGR

8.2%

Payout ratio

42%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$950.29

Full MRK calculator →

Portfolio growth — NIKLF vs MRK

📍 NIKLF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	NIKLF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, NIKLF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

NIKLF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NIKLF

Annual income on $10K today (after 15% tax)

$500,000.00/yr

After 10yr DRIP, annual income (after tax)

$248,956,422,516,494,340,000.00/yr

MRK

Annual income on $10K today (after 15% tax)

$276.16/yr

After 10yr DRIP, annual income (after tax)

$807.75/yr

At 15% tax rate, NIKLF beats the other by $248,956,422,516,494,340,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NIKLF + MRK for your $10,000?

NIKLF: 50%MRK: 50%

100% MRK50/50100% NIKLF

Portfolio after 10yr

$151342304066060.03M

Annual income

$146,444,954,421,467,270,000.00/yr

Blended yield

96.76%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

NIKLF

No analyst data

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+35.6% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NIKLF buys

MRK buys

No recent congressional trades found for NIKLF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricNIKLFMRK

Forward yield	5882.35% ✓	3.25%
Annual dividend / share	$2.00	$3.08 ✓
Payout ratio	50%	42% ✓
1-year div growth	0%	5.5% ✓
5-year div CAGR	0%	8.2% ✓
Portfolio after 10y	$302684608132120.06M ✓	$30.7K
Annual income after 10y	$292,889,908,842,934,530,000.00 ✓	$950.29
Total dividends collected	$302025190529273.63M ✓	$6.1K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: NIKLF vs MRK ($10,000, DRIP)

Year	NIKLF Portfolio	NIKLF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$598,935	$588,235.29	$11,192	$351.54	+$587.7K → NIKLF
2	$33,567,485	$32,926,624.20	$12,524	$392.70	+$33.55M → NIKLF
3	$1,760,572,584	$1,724,655,375.00	$14,015	$438.65	+$1760.56M → NIKLF
4	$86,422,145,745	$84,538,333,079.89	$15,682	$489.96	+$86422.13M → NIKLF
5	$3,970,768,237,328	$3,878,296,541,381.34	$17,547	$547.23	+$3970768.22M → NIKLF
6	$170,784,185,257,923	$166,535,463,243,981.50	$19,632	$611.16	+$170784185.24M → NIKLF
7	$6,876,898,713,370,412	$6,694,159,635,144,434.00	$21,963	$682.53	+$6876898713.35M → NIKLF
8	$259,275,158,018,476,900	$251,916,876,395,170,560.00	$24,571	$762.18	+$259275158018.45M → NIKLF
9	$9,153,924,569,332,272,000	$8,876,500,150,252,502,000.00	$27,486	$851.08	+$9153924569332.24M → NIKLF
10	$302,684,608,132,120,050,000	$292,889,908,842,934,530,000.00	$30,745	$950.29	+$302684608132120.06M → NIKLF

NIKLF vs MRK: Complete Analysis 2026

NIKLF — Stock

Nickel Rock Resources Inc. acquires, explores, and develops brine-based lithium and mineral resource properties in Canada and the United States. It holds interest in the Clayton Valley project covering an area of 2,300 acres in Nevada. The company was formerly known as Nevada Energy Metals Inc. and changed its name to Nickel Rock Resources Inc.in November 2020. Nickel Rock Resources Inc. was incorporated in 2011 and is headquartered in Vancouver, Canada.

Full NIKLF Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →

📬

Get this NIKLF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NIKLF vs SCHD NIKLF vs JEPI NIKLF vs O NIKLF vs KO NIKLF vs MAIN NIKLF vs JNJ NIKLF vs ABBV NIKLF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.